Pure Global

SARS-COV-2 NUCLEOCAPSID (N) ANTIGEN RAPID DETECTION KIT (COLLOIDAL GOLD METHOD), MARCA: SYNTHGENE - DIGEMID Registration DMDIV4295E

Access comprehensive regulatory information for SARS-COV-2 NUCLEOCAPSID (N) ANTIGEN RAPID DETECTION KIT (COLLOIDAL GOLD METHOD), MARCA: SYNTHGENE in the Peru medical device market through Pure Global AI's free database. This medical device is registered under DIGEMID ID DMDIV4295E and manufactured by NANJING SYNTHGENE MEDICAL TECHNOLOGY CO., LTD.. The device was registered on February 05, 2022.

This page provides complete registration details including product type (IN VITRO MEDICAL DEVICE), manufacturer information, authorized representative details, and regulatory compliance data from the official Peru DIGEMID medical device database. Pure Global AI offers free access to Peru's complete medical device registry.

Free Database
Powered by Pure Global AI
DIGEMID Official Data
DMDIV4295E
SARS-COV-2 NUCLEOCAPSID (N) ANTIGEN RAPID DETECTION KIT (COLLOIDAL GOLD METHOD), MARCA: SYNTHGENE
DIGEMID ID: DMDIV4295E
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Product Type
IN VITRO MEDICAL DEVICE
Registration Information
Analysis ID
DMDIV4295E
Registration Date
February 05, 2022
Expiration Date
February 05, 2027
Creation Date
March 10, 2025